| Absence of long-term changes in urine biomarkers after AKI: findings from the CRIC study | 36100915 | PMC9472364 | Journal | 2022 | 10.1186/s12882-022-02937-x | ASSESS-AKI | 20898, 21425, 23222 | Secondary Research |
| Achieved blood pressure post-acute kidney injury and risk of adverse outcomes after AKI: A prospective parallel cohort study. | 34325668 | PMC8320241 | Journal | 2021 | 10.1186/s12882-021-02480-1 | ASSESS-AKI | 20898, 21425, 22361, 23222 | Secondary Research |
| Acute Kidney Injury Ascertainment Is Affected by the Use of First Inpatient Versus Outpatient Baseline Serum Creatinine | 29340333 | PMC5762956 | Journal | 2017 | 10.1016/j.ekir.2017.08.011 | ASSESS-AKI | 20898, 21425 | Secondary Research |
| Acute Kidney Injury and Risk of CKD and Hypertension after Pediatric Cardiac Surgery. | 32948644 | PMC7536759 | Journal | 2020 | 10.2215/CJN.00150120 | ASSESS-AKI | 21586, 22028, 22361 | Secondary Research |
| Angiopoietins as Prognostic Markers for Future Kidney Disease and Heart Failure Events after Acute Kidney Injury. | 35017169 | PMC8975075 | Journal | 2022 | 10.1681/ASN.2021060757 | ASSESS-AKI | 20898, 21327, 21469, 21974, 22361, 22676 | Secondary Research |
| Assessment of kidney proximal tubular secretion in critical illness | 33886506 | PMC8262320 | Journal | 2021 | 10.1172/jci.insight.145514 | ASSESS-AKI | 22676 | Secondary Research |
| Biomarkers of inflammation and repair in kidney disease progression | 33290282 | PMC7843225 | Journal | 2021 | 10.1172/JCI139927 | ASSESS-AKI | 20898, 21425, 22361, 22676 | Secondary Research |
| Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment | 26948834 | PMC4921267 | Journal | 2016 | 10.1053/j.ajkd.2015.12.033 | ASSESS-AKI | 20898 | Secondary Research |
| Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury | 37292692 | | Journal | 2023 | 10.1101/2023.05.16.23290051 | AASK Trial, ASSESS-AKI | 23204 | Secondary Research |
| Contrast-Induced Acute Kidney Injury in the PRESERVE Trial | 29674341 | PMC5989683 | Journal | 2018 | 10.2215/CJN.01060118 | ASSESS-AKI | 20898, 21425 | Secondary Research |
| Employing urinary biomarkers to infer the absence of acute kidney disease in outpatients with a single serum creatinine measurement | 39593219 | | Journal | 2024 | https://doi.org/10.1080/0886022X.2024.2427161 | ASSESS-AKI | 23695 | Secondary Research |
| Evaluation of Plasma Biomarkers to Predict Major Adverse Kidney Events in Hospitalized Patients With COVID-19 | 37263570 | PMC10229201 | Journal | 2023 | 10.1053/j.ajkd.2023.03.010 | ASSESS-AKI | 22361 | Secondary Research |
| Genome-wide Association Study for Acute Kidney Injury. | 37273234 | PMC10371295 | Journal | 2023 | 10.34067/KID.0000000000000175 | ASSESS-AKI | 22676 | Secondary Research |
| Impact of AKI on Urinary Protein Excretion: Analysis of Two Prospective Cohorts. | 31235617 | PMC6622423 | Journal | 2019 | 10.1681/ASN.2018101036 | ASSESS-AKI | 20898, 21425 | Secondary Research |
| Improving Care for Patients after Hospitalization with AKI | 32912935 | PMC7609013 | Journal | 2020 | 10.1681/ASN.2020040397 | ASSESS-AKI | 20898, 21425 | Secondary Research |
| Inferring trends in renal function based on a single serum creatinine with a spot urine creatinine-to-osmolality ratio in outpatient settings | | | Conference Presentation | 2024 | | ASSESS-AKI | 23695 | Secondary Research |
| Inferring trends in renal function based on a single serum creatinine with a spot urine creatinine-to-osmolality ratio in outpatient settings | | | Conference Presentation | 2024 | | ASSESS-AKI | 23695 | Secondary Research |
| Kidney injury biomarkers 5 years after AKI due to pediatric cardiac surgery | 29511889 | PMC5945328 | Journal | 2018 | 10.1007/s00467-018-3888-4 | ASSESS-AKI | 21586 | Secondary Research |
| Long-Term Kidney Outcomes Following Dialysis-Treated Childhood Acute Kidney Injury: A Population-Based Cohort Study | 34039667 | PMC8455253 | Journal | 2021 | 10.1681/ASN.2020111665 | ASSESS-AKI | 21586, 22028 | Secondary Research |
| Longitudinal biomarkers and kidney disease progression after acute kidney injury. | 36951957 | PMC10243801 | Journal | 2023 | 10.1172/jci.insight.167731 | ASSESS-AKI | 20898, 21425, 22361 | Secondary Research |
| Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies. | 36108888 | PMC9868060 | Journal | 2023 | 10.1053/j.ajkd.2022.08.007 | ASSESS-AKI | 20898, 21327, 21425, 21469, 21974, 22361, 22676 | Secondary Research |
| Post-Acute Kidney Injury Proteinuria and Subsequent Kidney Disease Progression: The Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study. | 31985750 | PMC6990681 | Journal | 2020 | 10.1001/jamainternmed.2019.6390 | ASSESS-AKI | 20898 | Secondary Research |
| Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury. | 33272913 | PMC7792656 | Journal | 2020 | 10.2215/CJN.10840720 | ASSESS-AKI | 20898, 21425, 22361 | Secondary Research |
| Storage Time and Urine Biomarker Levels in the ASSESS-AKI Study. | 27788160 | PMC5082822 | Journal | 2016 | 10.1371/journal.pone.0164832 | ASSESS-AKI | 20898 | Secondary Research |
